EUVIMEDEUVIMED entdecken
Multizentrische Studie

Excessive lymph node dissection compromises efficacy of postsurgical immunotherapy for gastric cancer:A multicenter retrospective study

Jianming Yang, Jiarong You, Tingzhen Li, Zhenbin Zhang, Wenlong Zeng, Qian Wang, Chi Chen, Yiquan Li, Chongyang Li, Zhaofeng Yi, Lijun Huang, Rongpu Liang und 5 weitere

Cancer Letters · 2026

DOI: 10.1016/j.canlet.2026.218550 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Letters, 2026. Verfasst von Jianming Yang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Lymph Node Excision, Immunotherapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Guangzhou Science and Technology Program Key Projects, Sun Yat-Sen University, Guangdong Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy of postsurgical immunotherapy for gastric cancer (GC) remains controversial, and the effect of the number of dissected lymph nodes (DLNs) on the efficacy of immunotherapy remains unknown. We retrospectively reviewed 451 patients who received adjuvant or palliative therapies (including immunotherapy and chemotherapy) for GC at nationwide centers between 2020 and 2025 to investigate the influence of DLNs on postsurgical immunotherapy. Prognoses were assessed based on DLNs. In the adjuvant immunotherapy cohort (n = 139), the disease-free survival (DFS) was significantly lower in patients with DLNs >36 compared with those with DLNs ≤36 [hazard ratio (HR), 2.62; 95% confidence interval (CI), 1.39-4.95, P = 0.003)]. Moreover, patients with DLNs≤36 who received combined immunotherapy had a better DFS than patients who received only adjuvant chemotherapy (HR, 0.37; 95% CI, 0.17-0.78, P = 0.006). In the palliative immunotherapy cohort (n = 47), patients with DLNs>36 had significantly lower progression-free survival (PFS) (HR, 3.57; 95% CI, 1.61-7.94, P = 0.001) and DCR (6.67% vs 65.6%, P 0 to ≤36, and DLNs>36 (median PFS, 16 vs. 11 vs. 3 months, P = 0.002). In conclusion, excessive lymph node dissection (DLNs≥36) compromised the efficacy of postsurgical adjuvant or palliative immunotherapy for GC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsLymph Node ExcisionImmunotherapyHumansRetrospective StudiesFemaleMaleMiddle AgedAgedChemotherapy, AdjuvantPrognosisGastrectomyLymphatic MetastasisProgression-Free SurvivalAdultLymph NodesDisease-Free Survival

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
  • Department of Gastrointestinal Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Gastrointestinal Surgery, Yu Huang Ding Hospital, Yan Tai, Shandong, China.
  • Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Yuedong Hospital, Meizhou, Guangdong, China.
  • Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Electronic address: dingdb@mail3.sysu.edu.cn.
  • Department of Gastrointestinal Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China. Electronic address: luli8@mail.sysu.edu.cn.

Förderung

  • Guangzhou Science and Technology Program Key Projects
  • Sun Yat-Sen University
  • Guangdong Provincial Department of Science and Technology
  • Science and Technology Planning Project of Guangdong Province

Zitieren

APA

Yang, J., You, J., Li, T., Zhang, Z., Zeng, W., Wang, Q., Chen, C., Li, Y., Li, C., Yi, Z., Huang, L., Liang, R., Wang, H., Huang, H., Ding, D., Lu, L., & Wei, B. (2026). Excessive lymph node dissection compromises efficacy of postsurgical immunotherapy for gastric cancer:A multicenter retrospective study. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218550

Vancouver

Yang J, You J, Li T, Zhang Z, Zeng W, Wang Q, et al. Excessive lymph node dissection compromises efficacy of postsurgical immunotherapy for gastric cancer:A multicenter retrospective study. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218550

BibTeX
@article{Yang2026,
  author = {Yang, Jianming and You, Jiarong and Li, Tingzhen and Zhang, Zhenbin and Zeng, Wenlong and Wang, Qian and Chen, Chi and Li, Yiquan and Li, Chongyang and Yi, Zhaofeng and Huang, Lijun and Liang, Rongpu and Wang, Han and Huang, He and Ding, Dongbing and Lu, Li and Wei, Bo},
  title = {Excessive lymph node dissection compromises efficacy of postsurgical immunotherapy for gastric cancer:A multicenter retrospective study},
  journal = {Cancer Letters},
  year = {2026},
  doi = {10.1016/j.canlet.2026.218550}
}
Kostenlos starten →